Alamar Biosciences, Inc. (NASDAQ:ALMR – Get Free Report)’s stock price hit a new 52-week high during trading on Tuesday following a stronger than expected earnings report. Get Alamar Biosciences alerts:Key Stories Impacting Alamar BiosciencesHere are the key news stories impacting Alamar Biosciences this week:Positive Sentiment: Alamar reported second-quarter revenue of $29.43 million , while its adjusted loss of $0.22 per share was better than the analyst consensus loss of $0.36. Finally, Bank of America started coverage on shares of Alamar Biosciences in a research report on Tuesday, May 12th. Alamar Biosciences Company Profile(Get Free Report)Our mission is to power precision proteomics to enable the earliest detection of disease. Further ReadingReceive News & Ratings for Alamar Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alamar Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.